Genotypic Technology announced its partnership with Premier Medical Corporation (PMC) USA for the distribution of rapid antigen and antibody kits. PMC is a reputed manufacturer of rapid tests of various diseases such as malaria, HIV, Hepatitis B and C, dengue and Syphilis, and has ISO certified world-class manufacturing facilities in Gujarat.

Genotypic collaborated with PMC during the first wave of COVID-19 to develop rapid & reliable COVID-19 diagnostic products that will help in screening SARS CoV-2 in less than 20 minutes. 

Commenting on the announcement, Dr Raja Mugasimangalam, Founder and CEO, Genotypic Technology said, “We have been using the antigen and antibody tests to safeguard Genotypic, Dhitiomics and QTLomics workplaces. Genotypic has been working with several technology companies to provide SARS-CoV-2 sequencing solutions to more than 1400 Indian COVID testing Labs. We are pleased to work with PMC on taking this rapid test to India and selected countries across the globe to support the fight against the COVID-19 pandemic."

Nilesh Mehta, CEO and President, Premier Medical Corporation, NJ, USA added “PMC and Genotypic have collaborated to develop antigen and antibody kits for COVID-19 to cater to the community to accelerate testing as per the new guidelines. In addition to this, we also plan to co-develop novel proteins for differential diagnostics of various infectious diseases such as dengue, chikungunya, zika, ebola and others. We are elated to be able to work together to support the community in these testing times.”